Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial.
about
Efficacy of antidepressive medication for depression in Parkinson disease: a network meta-analysis.Cognitive decline in Parkinson disease.Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1.A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease.Mild Cognitive Impairment in Parkinson's Disease-What Is It?
P2860
Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo-controlled trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Rasagiline for mild cognitive ...... e: A placebo-controlled trial.
@en
Rasagiline for mild cognitive ...... e: A placebo-controlled trial.
@nl
type
label
Rasagiline for mild cognitive ...... e: A placebo-controlled trial.
@en
Rasagiline for mild cognitive ...... e: A placebo-controlled trial.
@nl
prefLabel
Rasagiline for mild cognitive ...... e: A placebo-controlled trial.
@en
Rasagiline for mild cognitive ...... e: A placebo-controlled trial.
@nl
P2093
P2860
P356
P1433
P1476
Rasagiline for mild cognitive ...... e: A placebo-controlled trial.
@en
P2093
Azhar Choudhry
Daniel Weintraub
Fernando Pagan
Jordan J Elm
MODERATO Investigators
Matthew D Davis
P2860
P304
P356
10.1002/MDS.26617
P407
P577
2016-03-31T00:00:00Z